These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35750335)
1. Therapeutic Effect of Anti-CD52 Monoclonal Antibody in Multiple Sclerosis and Its Animal Models Is Mediated via T Regulatory Cells. Kiapour N; Wu B; Wang Y; Seyedsadr M; Kapoor S; Zhang X; Elzoheiry M; Kasimoglu E; Wan Y; Markovic-Plese S J Immunol; 2022 Jul; 209(1):49-56. PubMed ID: 35750335 [TBL] [Abstract][Full Text] [Related]
2. Differential reconstitution of T cell subsets following immunodepleting treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with relapsing-remitting multiple sclerosis. Zhang X; Tao Y; Chopra M; Ahn M; Marcus KL; Choudhary N; Zhu H; Markovic-Plese S J Immunol; 2013 Dec; 191(12):5867-74. PubMed ID: 24198283 [TBL] [Abstract][Full Text] [Related]
3. Alteration of CD39+Foxp3+ CD4 T cell and cytokine levels in EAE/MS following anti-CD52 treatment. Pant AB; Wang Y; Mielcarz DW; Kasper EJ; Telesford KM; Mishra M; Haque A; Channon JY; Kasper LH; Begum-Haque S J Neuroimmunol; 2017 Feb; 303():22-30. PubMed ID: 28087077 [TBL] [Abstract][Full Text] [Related]
4. S3I-201, a selective stat3 inhibitor, ameliorates clinical symptoms in a mouse model of experimental autoimmune encephalomyelitis through the regulation of multiple intracellular signalling in Th1, Th17, and treg cells. Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Mazroua HA; Alomar HA; Al-Hamamah MA; Attia SM Mult Scler Relat Disord; 2023 May; 73():104658. PubMed ID: 36989705 [TBL] [Abstract][Full Text] [Related]
6. Depletion of CD52-positive cells inhibits the development of central nervous system autoimmune disease, but deletes an immune-tolerance promoting CD8 T-cell population. Implications for secondary autoimmunity of alemtuzumab in multiple sclerosis. von Kutzleben S; Pryce G; Giovannoni G; Baker D Immunology; 2017 Apr; 150(4):444-455. PubMed ID: 27925187 [TBL] [Abstract][Full Text] [Related]
7. MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alasmari AF; Shahid M; Al-Mazroua HA; Alomar HA; AsSobeai HM; Alshamrani AA; Attia SM Eur J Pharmacol; 2023 Nov; 959():176086. PubMed ID: 37832863 [TBL] [Abstract][Full Text] [Related]
9. Role of IL-16 in CD4+ T cell-mediated regulation of relapsing multiple sclerosis. Skundric DS; Cruikshank WW; Drulovic J J Neuroinflammation; 2015 Apr; 12():78. PubMed ID: 25896927 [TBL] [Abstract][Full Text] [Related]
10. Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulation. Esposito M; Ruffini F; Bellone M; Gagliani N; Battaglia M; Martino G; Furlan R J Neuroimmunol; 2010 Mar; 220(1-2):52-63. PubMed ID: 20149931 [TBL] [Abstract][Full Text] [Related]
11. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326 [TBL] [Abstract][Full Text] [Related]
12. Ivermectin Protects Against Experimental Autoimmune Encephalomyelitis in Mice by Modulating the Th17/Treg Balance Involved in the IL-2/STAT5 Pathway. Xie Y; Jin C; Sang H; Liu W; Wang J Inflammation; 2023 Oct; 46(5):1626-1638. PubMed ID: 37227550 [TBL] [Abstract][Full Text] [Related]
13. Anti-mouse CD52 Treatment Ameliorates Colitis through Suppressing Th1/17 Mediated Inflammation and Promoting Tregs Differentiation in IL-10 Deficient Mice. Liu J; Wang H; Li Y; Shi P; Gong J; Gu L; Zhu W; Li J Biol Pharm Bull; 2018 Sep; 41(9):1423-1429. PubMed ID: 29899181 [TBL] [Abstract][Full Text] [Related]
14. Histamine H4 Receptor Antagonist Ameliorates the Progression of Experimental Autoimmune Encephalomyelitis via Regulation of T-Cell Imbalance. Aldossari AA; Assiri MA; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Albekairi TH; Alomar HA; Al-Mazroua HA; Almanaa TN; Al-Hamamah MA; Alwetaid MY; Ahmad SF Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894952 [TBL] [Abstract][Full Text] [Related]
15. Ex vivo expanded regulatory T cells CD4 Lifshitz GV; Zhdanov DD; Lokhonina AV; Eliseeva DD; Lyssuck EY; Zavalishin IA; Bykovskaia SN Autoimmunity; 2016 Sep; 49(6):388-396. PubMed ID: 27424664 [TBL] [Abstract][Full Text] [Related]